TCIRG1 and nonpapillary renal cell carcinoma: In addition, high expression of TCIRG1 was associated with malignancy progression and poor prognosis in ccRCC patients, and positively correlated with the immunoinhibitors PDCD1 and CTLA4 (Fig. 4G), and IFN-γ as well (Fig. 2A).